Source: Business Wire

Press Release: Deep Genomics : Deep Genomics to Present at the 2023 Elevate Festival

TORONTO--(BUSINESS WIRE)-- #AI--Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced today that its founder and Chief Innovation Officer, Brendan Frey, Ph.D., F.R.S.C., will present at the 2023 Elevate Festival in Toronto on Tuesday, September 26, 2022, at 6:35 PM EST. Brendan's remarks, titled Beacons of Hope: AI in Medicine will highlight recent advances in the use of Artificial Intelligence (AI) and deep learning for drug di

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Brian O’Callaghan's photo - CEO of Deep Genomics

CEO

Brian O’Callaghan

CEO Approval Rating

82/100

Read more